Strategies for the treatment of acute benzodiazepine toxicity in a clinical setting: the role of antidotes

References

• Gaudreault P, Guay J, Thivierge RL, et al Benzodiazepine poisoning. clinical and pharmacological considerations and treatment. Drug Saf. 1991;6(4):247–265.
   PubMed Web of Science ®Google Scholar
• Liu S, O’Donnell J, Gladden RM, et al Trends in nonfatal and fatal overdoses involving benzodiazepines - 38 states and the district of Columbia, 2019-2020. MMWR Morb Mortal Wkly Rep. 2021;70(34):1136–1141.
   PubMed Web of Science ®Google Scholar
• Kyong YY, Park JT, Choi KH. Serial monitoring of sedation scores in benzodiazepine overdose. Am J Emerg Med. 2014;32(11):1438.e5–6.
   Web of Science ®Google Scholar
• Buckley NA, Dawson AH, Whyte IM, et al Relative toxicity of benzodiazepines in overdose. BMJ. 1995;310(6974):219–221.
   PubMed Web of Science ®Google Scholar
• Love JN, Litovitz TL, Howell JM, et al Characterization of fatal beta blocker ingestion: a review of the American association of poison control centers data from 1985 to 1995. J Toxicol Clin Toxicol. 1997;35(4):353–359.
   PubMed Web of Science ®Google Scholar
• Weinbroum AA, Flaishon R, Sorkine P, et al. A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose. Drug Saf. 1997;17(3):181–196.
   PubMed Web of Science ®Google Scholar
• Hassanian-Moghaddam H, Zamani N, Rahimi M, et al Acute adult and adolescent poisoning in Tehran, Iran; the epidemiologic trend between 2006 and 2011. Arch Iran Med. 2014;17(8):534–538.
   PubMed Web of Science ®Google Scholar
• Hadeiy SK, Parhizgar P, Hassanian-Moghaddam H, et al. Trends of acute drug and chemical toxicities in adults and adolescents in Tehran, Iran between 2012 and 2018: a retrospective chart review. Drug Chem Toxicol. 2021;1–10. DOI:10.1080/01480545.2021.1903486
   PubMed Web of Science ®Google Scholar
• Naguib M, El Gammal M, Elhattab YS, et al Midazolam for caudal analgesia in children: comparison with caudal bupivacaine. Can J Anaesth. 1995;42(9):758–764.
   PubMed Web of Science ®Google Scholar
• Haefely WE. Pharmacology of the benzodiazepine receptor. Eur Arch Psychiatry Neurol Sci. 1989;238(5–6):294–301.
   PubMedGoogle Scholar
• Garzone PD, Kroboth PD. Pharmacokinetics of the newer benzodiazepines. Clin Pharmacokinet. 1989;16(6):337–364.
   PubMed Web of Science ®Google Scholar
• Höjer J, Baehrendtz S, Gustafsson L. Benzodiazepine poisoning: experience of 702 admissions to an intensive care unit during a 14-year period. J Intern Med. 1989;226(2):117–122.
   PubMed Web of Science ®Google Scholar
• Busto U, Kaplan HL, Sellers EM. Benzodiazepine-associated emergencies in Toronto. Am J Psychiatry. 1980;137:224–227.
   PubMed Web of Science ®Google Scholar
• Yardan T, Acar E, Akdemir HU, et al Is the flumazenil administration diagnosis or treatment? Two case reports. J Experimental Clin Med. 2013;30(4):395–397.
   Google Scholar
• Whitelaw AG, Cummings AJ, McFadyen IR. Effect of maternal lorazepam on the neonate. Br Med J (Clin Res Ed). 1981;282(6270):1106–1108.
   PubMed Web of Science ®Google Scholar
• Gei AF, Suarez VR, Van Hook JW. 39 Overdose, poisoning and envenomation during pregnancy. In: Critical care obstertics. 6th ed. 2010.
   Google Scholar
• Stahl MM, Saldeen P, Vinge E. Reversal of fetal benzodiazepine intoxication using flumazenil. Br J Obstet Gynaecol. 1993;100(2):185–188.
   PubMedGoogle Scholar
• Vukcević NP, Ercegović GV, Segrt Z, et al Benzodiazepine poisoning in elderly. Vojnosanit Pregl. 2016;73(3):234–238.
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. therapeutic considerations (part I). Clin Pharmacokinet. 1991;21(3):165–177.
   PubMed Web of Science ®Google Scholar
• Boccuzzi-Chmura L, Robertson DC. Flumazenil (romazicon) and the patient with benzodiazepine overdose: risks versus benefits. J Emerg Nurs. 1996;22(4):330–333.
   PubMedGoogle Scholar
• Kagota S, Morikawa K, Ishida H, et al. Vasorelaxant effects of benzodiazepines, non-benzodiazepine sedative-hypnotics, and tandospirone on isolated rat arteries. Eur J Pharmacol. 2021;892:173744.
   PubMed Web of Science ®Google Scholar
• Saleem U, Mahmood S, Ahmad B, et al Benzodiazepine poisoning cases: a retrospective study from Faisalabad, Pakistan. Pak J Pharm. 2010;23:11–13.
   Google Scholar
• Krayeva YV, Brusin KM, Bushuev AV, et al Pre-hospital management and outcome of acute poisonings by ambulances in Yekaterinburg, Russia. Clin Toxicol (Phila). 2013;51(8):752–760.
   PubMed Web of Science ®Google Scholar
• Mordel A, Winkler E, Almog S, et al Seizures after flumazenil administration in a case of combined benzodiazepine and tricyclic antidepressant overdose. Crit Care Med. 1992;20(12):1733–1734.
   PubMed Web of Science ®Google Scholar
• Hunkeler W, Möhler H, Pieri L, et al Selective antagonists of benzodiazepines. Nature. 1981;290(5806):514–516.
   PubMed Web of Science ®Google Scholar
• An H, Godwin J. Flumazenil in benzodiazepine overdose. Cmaj. 2016;188(17–18):E537.
   PubMed Web of Science ®Google Scholar
• Zell M, Timm U. Highly sensitive assay of benzodiazepine antagonist in plasma by capillary gas chromatography with nitrogen-selective detection. J Chromatogr. 1986;382:175–188.
   PubMed Web of Science ®Google Scholar
• Roncari G, Ziegler WH, Guentert TW. Pharmacokinetics of the new benzodiazepine antagonist ro 15-1788 in man following intravenous and oral administration. Br J Clin Pharmacol. 1986;22(4):421–428.
   PubMed Web of Science ®Google Scholar
• Galletly DC, Ure R, Turley A. Flumazenil: a twelve-month survey of use in a New Zealand public hospital. Anaesth Intensive Care. 1990;18(2):229–233.
   PubMed Web of Science ®Google Scholar
• Ritz R, Zuber M, Elsasser S, et al Use of flumazenil in intoxicated patients with coma. A double-blind placebo-controlled study in ICU. Intensive Care Med. 1990;16(4):242–247.
   PubMed Web of Science ®Google Scholar
• Prischl F, Donner A, Grimm G, et al Value of flumazenil in benzodiazepine self-poisoning. Med Toxicol Adverse Drug Exp. 1988;3(4):334–339.
   PubMedGoogle Scholar
• Sprenger H, Sharpe MD, McLachlan RS. Flumazenil as a diagnostic tool in the differential diagnosis of coma in a critically ill patient. Can J Anaesth. 1994;41(1):52–55.
   PubMed Web of Science ®Google Scholar
• Winkler E, Almog S, Kriger D, et al Use of flumazenil in the diagnosis and treatment of patients with coma of unknown etiology. Crit Care Med. 1993;21(4):538–542.
   PubMed Web of Science ®Google Scholar
• Aarseth HP, Bredesen JE, Grynne B, et al Benzodiazepine-receptor antagonist, a clinical double blind study. J Toxicol Clin Toxicol. 1988;26(5–6):283–292.
   PubMed Web of Science ®Google Scholar
• Greene SL, Dargan PI, Jones AL. Acute poisoning: understanding 90% of cases in a nutshell. Postgrad Med J. 2005;81(954):204–216.
   PubMed Web of Science ®Google Scholar
• Ngo AS, Anthony CR, Samuel M, et al Should a benzodiazepine antagonist be used in unconscious patients presenting to the emergency department?. Resuscitation. 2007;74(1):27–37.
   PubMed Web of Science ®Google Scholar
• Weinbroum A, Halpern P, Geller E. The use of flumazenil in the management of acute drug poisoning–a review. Intensive Care Med. 1991;17(S1):S32–8.
   PubMedGoogle Scholar
• Penninga EI, Graudal N, Ladekarl MB, et al adverse events associated with flumazenil treatment for the management of suspected benzodiazepine intoxication–a systematic review with meta-analyses of randomised trials. Basic Clin Pharmacol Toxicol. 2016;118(1):37–44.
   PubMed Web of Science ®Google Scholar
• Gueye PN, Hoffman JR, Taboulet P, et al Empiric use of flumazenil in comatose patients: limited applicability of criteria to define low risk. Ann Emerg Med. 1996;27(6):730–735.
   PubMed Web of Science ®Google Scholar
• Weinbroum A, Rudick V, Sorkine P, et al Use of flumazenil in the treatment of drug overdose: a double-blind and open clinical study in 110 patients. Crit Care Med. 1996;24(2):199–206.
   PubMed Web of Science ®Google Scholar
• Höjer J, Baehrendtz S, Matell G, et al Diagnostic utility of flumazenil in coma with suspected poisoning: a double blind, randomised controlled study. BMJ. 1990;301(6764):1308–1311.
   PubMedGoogle Scholar
• Höjer J, Baehrendtz S. The effect of flumazenil (ro 15-1788) in the management of self-induced benzodiazepine poisoning. A double-blind controlled study. Acta Med Scand. 1988;224(4):357–365.
   PubMedGoogle Scholar
• Geller E, Niv D, Rudick V, et al The use of ro 15–1788: a benzodiazepine antagonist in the diagnosis and treatment of benzodiazepine overdose. J American Soc Anesthesiol. 1984;61(3):A135–A135.
   Google Scholar
• Geller E, Niv D, Weinbrum A, et al. The use of flumazenil in the treatment of 34 intoxicated patients. Resuscitation. 1988;16:S57–62.
   PubMedGoogle Scholar
• Kleinberger G, Grimm G, Laggner A, et al Weaning patients from mechanical ventilation by benzodiazepine antagonist ro15-1788. Lancet. 1985;2(8449):268–269.
   PubMed Web of Science ®Google Scholar
• Barnett R, Grace M, Boothe P, et al Flumazenil in drug overdose: randomized, placebo-controlled study to assess cost effectiveness. Crit Care Med. 1999;27(1):78–81.
   PubMed Web of Science ®Google Scholar
• Haverkos GP, DiSalvo RP, Imhoff TE. Fatal seizures after flumazenil administration in a patient with mixed overdose. Ann Pharmacother. 1994;28(12):1347–1349.
   PubMed Web of Science ®Google Scholar
• Mathieu-Nolf M, Babé MA, Coquelle-Couplet V, et al Flumazenil use in an emergency department: a survey. J Toxicol Clin Toxicol. 2001;39(1):15–20.
   PubMed Web of Science ®Google Scholar
• Martens F, Köppel C, Ibe K, et al Clinical experience with the benzodiazepine antagonist flumazenil in suspected benzodiazepine or ethanol poisoning. J Toxicol Clin Toxicol. 1990;28(3):341–356.
   PubMed Web of Science ®Google Scholar
• Gonzalez N, O’Sullivan F. The poisoned patient. Anaesthesia Intens Care Med. 2019;20(11):630–634.
   Web of Science ®Google Scholar
• Muñoz-Solomando A, Kendall T, Whittington CJ. Cognitive behavioural therapy for children and adolescents. Curr Opin Psychiatry. 2008;21(4):332–337.
   PubMed Web of Science ®Google Scholar
• Razavizadeh AS, Zamani N, Ziaeefar P, et al Protective effect of flumazenil infusion in severe acute benzodiazepine toxicity: a pilot randomized trial. Eur J Clin Pharmacol. 2021;77(4):547–554.
   PubMed Web of Science ®Google Scholar
• Pajoumand A, Hassanian-Moghaddam H, Zamani N. Letter to the editor, response to: adverse events associated with flumazenil treatment for the management of suspected benzodiazepine intoxication – a systematic review with meta-analyses of randomized trials. Basic Clin Pharmacol Toxicol. 2016;118(5):323–324.
   PubMed Web of Science ®Google Scholar
• Schult RF, Omar D, Wiegand TJ, et al. Experience with lower dose flumazenil at an academic medical center. Am J Emerg Med. 2021;49:399–401.
   PubMed Web of Science ®Google Scholar
• Mathus-Vliegen EM, de Jong L, Kos-Foekema HA. Significant and safe shortening of the recovery time after flumazenil-reversed midazolam sedation. Dig Dis Sci. 2014;59(8):1717–1725.
   PubMed Web of Science ®Google Scholar
• Chern CH, Chern TL, Wang LM, et al Continuous flumazenil infusion in preventing complications arising from severe benzodiazepine intoxication. Am J Emerg Med. 1998;16(3):238–241.
   PubMed Web of Science ®Google Scholar
• Burkhart KK, Kulig KW. The diagnostic utility of flumazenil (a benzodiazepine antagonist) in coma of unknown etiology. Ann Emerg Med. 1990;19(3):319–321.
   PubMed Web of Science ®Google Scholar
• Lugoboni F, Faccini M, Quaglio GL, et al Intravenous flumazenil infusion to treat benzodiazepine dependence should be performed in the inpatient clinical setting for high risk of seizure. J Psychopharmacol. 2011;25(6):848–849.
   PubMed Web of Science ®Google Scholar
• Amrein R, Leishman B, Bentzinger C, et al Flumazenil in benzodiazepine antagonism. actions and clinical use in intoxications and anaesthesiology. Med Toxicol Adverse Drug Exp. 1987;2(6):411–429.
   PubMedGoogle Scholar
• Lheureux P, Askenasi R. Benzodiazepine antagonist ro 15-1788 in self-poisoning. Arch Intern Med. 1986;146(6):1241.
   PubMedGoogle Scholar
• Kulka PJ, Lauven PM. Benzodiazepine antagonists. an update of their role in the emergency care of overdose patients. Drug Saf. 1992;7(5):381–386.
   PubMed Web of Science ®Google Scholar
• Brouard A, Perdu E, Bismuth C. Ro 15-1788–anexate (benzodiazepine antagonist). J Toxicol Clin Exp. 1987;7(4):223–237.
   PubMedGoogle Scholar
• Herman RJ, Wilkinson GR. Disposition of diazepam in young and elderly subjects after acute and chronic dosing. Br J Clin Pharmacol. 1996;42(2):147–155.
   PubMed Web of Science ®Google Scholar
• ElDesoky ES. Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther. 2007;14(5):488–498.
   PubMedGoogle Scholar
• Trifirò G, Spina E. Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems. Curr Drug Metab. 2011;12(7):611–620.
   PubMed Web of Science ®Google Scholar
• Hodgkinson DW, Driscoll P. Diagnostic utility of flumazenil in coma with suspected poisoning. BMJ. 1991;302(6770):238.
   PubMedGoogle Scholar
• Geller E, Crome P, Schaller MD, et al Risks and benefits of therapy with flumazenil (Anexate) in mixed drug intoxications. Eur Neurol. 1991;31(4):241–250.
   PubMed Web of Science ®Google Scholar
• Veiraiah A, Dyas J, Cooper G, et al Flumazenil use in benzodiazepine overdose in the UK: a retrospective survey of NPIS data. Emerg Med J. 2012;29(7):565–569.
   PubMed Web of Science ®Google Scholar
• Spivey WH. Flumazenil and seizures: analysis of 43 cases. Clin Ther. 1992;14(2):292–305.
   PubMed Web of Science ®Google Scholar
• Seger DL. Flumazenil–treatment or Toxin. J Toxicol Clin Toxicol. 2004;42(2):209–216.
   PubMed Web of Science ®Google Scholar
• Dunton AW, Schwam E, Pitman V, et al. Flumazenil: US clinical pharmacology studies. Eur J Anaesthesiol Suppl. 1988;2:81–95.
   PubMedGoogle Scholar
• Lheureux P, Askenasi R. Agonism and antagonism at the benzodiazepine-receptor: a new concept for new approach of common drug poisoning. Acta Anaesthesiol Belg. 1989;40(1):23–28.
   PubMedGoogle Scholar
• Spivey WH, Roberts JR, Derlet RW. A clinical trial of escalating doses of flumazenil for reversal of suspected benzodiazepine overdose in the emergency department. Ann Emerg Med. 1993;22(12):1813–1821. .
   PubMed Web of Science ®Google Scholar
• Patel SR. Toxicologic emergencies in the intensive care unit: management using reversal agents and antidotes. Crit Care Nurs Q. 2013;36(4):335–344.
   PubMedGoogle Scholar
• Takemoto CK, Hodding JH, Kraus DM. Pediatric dosage handbook. In: Pediatric dosage handbook. 10th ed. 2003. p. 1418.
   Google Scholar
• Wiley CC, Wiley JF. 2nd. Pediatric benzodiazepine ingestion resulting in hospitalization. J Toxicol Clin Toxicol. 1998;36(3):227–231.
   PubMed Web of Science ®Google Scholar
• Kreshak AA, Tomaszewski CA, Clark RF, et al Flumazenil administration in poisoned pediatric patients. Pediatr Emerg Care. 2012;28:448–450.
   PubMed Web of Science ®Google Scholar
• Hofer P, Scollo-Lavizzari G. Benzodiazepine antagonist ro 15-1788 in self-poisoning. Diagnostic and therapeutic use. Arch Intern Med. 1985;145(4):663–664.
   PubMedGoogle Scholar
• Karavokiros KA, Tsipis GB. Flumazenil: a benzodiazepine antagonist. Dicp. 1990;24(10):976–981.
   PubMedGoogle Scholar
• Leykin Y, Halpern P, Silbiger A, et al Acute poisoning treated in the intensive care unit: a case series. Isr J Med Sci. 1989;25(2):98–102.
   PubMedGoogle Scholar
• Bodenham A, Brownlie G, Dixon JS, et al Reversal of sedation by prolonged infusion of flumazenil (Anexate, ro 15-1788). Anaesthesia. 1988;43(5):376–378.
   PubMed Web of Science ®Google Scholar
• Maxa JL, Ogu CC, Adeeko MA, et al Continuous-infusion flumazenil in the management of chlordiazepoxide toxicity. Pharmacotherapy. 2003;23(11):1513–1516.
   PubMed Web of Science ®Google Scholar
• Razavizadeh AS, Zamani N, Ziaeefar P, et al. Correction to: protective effect of flumazenil infusion in severe acute benzodiazepine toxicity: a pilot randomized trial. Eur J Clin Pharmacol. 2021 Apr;77(4):555–556.
   PubMed Web of Science ®Google Scholar
• Burton JH, Lyon L, Dorfman T, et al Continuous flumazenil infusion in the treatment of zolpidem (Ambien) and ethanol coingestion. J Toxicol Clin Toxicol. 1998;36(7):743–746.
   PubMed Web of Science ®Google Scholar
• Solhi H, Mostafazadeh B, Vishteh HR, et al Benefit effect of naloxone in benzodiazepines intoxication: findings of a preliminary study. Hum Exp Toxicol. 2011;30(7):535–540.
   PubMed Web of Science ®Google Scholar
• Wolkowitz OM, Tinklenberg JR. Naloxone’s effect on cognitive functioning in drug-free and diazepam-treated normal humans. Psychopharmacology (Berl). 1985;85(2):221–223.
   PubMed Web of Science ®Google Scholar
• Stirt JA. Aminophylline is a diazepam antagonist. Anesth Analg. 1981;60(10):767–768.
   PubMed Web of Science ®Google Scholar
• Katz Y, Gavish M. Aminophylline reversal of diazepam intoxication. Lancet. 1989;1(8643):900–901.
   PubMed Web of Science ®Google Scholar
• Aghabiklooei A, Sangsefidi J. The effects of intravenous aminophylline on level of consciousness in acute intentional benzodiazepines poisoning in comparison to flumazenil. Hum Exp Toxicol. 2017;36(3):311–316.
   PubMed Web of Science ®Google Scholar
• Traeger SM, Haug MT. 3rd. Reduction of diazepam serum half life and reversal of coma by activated charcoal in a patient with severe liver disease. J Toxicol Clin Toxicol. 1986;24(4):329–337.
   PubMed Web of Science ®Google Scholar
• Dobisova A, Vavrinec P, Vavrincova-Yaghi D, et al. Case report: enhanced diazepam elimination with the molecular adsorbents recirculating system (MARS) in severe autointoxication: a survival case report. Front Med (Lausanne). 2021;8:633250.
   PubMed Web of Science ®Google Scholar